BIOTAGE ABBIOTAGE ABBIOTAGE AB

BIOTAGE AB

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.06EUR
Revenue estimate
‪42.70 M‬EUR
Market capitalization
‪1.13 B‬EUR
‪22.00 M‬EUR
‪166.51 M‬EUR
‪65.46 M‬
Beta (1Y)
1.30

About BIOTAGE AB

CEO
Torben Vedel Stahl Jörgensen
Headquarters
Uppsala
Employees (FY)
674
Founded
1997
ISIN
SE0000454746
FIGI
BBG000C2V1P7
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products and services include sample preparation, horizon food and environmental products, organic synthesis, peptide chemistry, flash purification, work-up products, evaporation and concentration, and service and support. The company was founded by Pal Nyren, Carl Erik Mathias Uhlen, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Bjorn Ekstrom in 1969 and is headquartered in Uppsala, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange BIOTAGE AB stocks are traded under the ticker PQX1.
BIOTAGE AB is going to release the next earnings report on Jul 16, 2024. Keep track of upcoming events with our Earnings Calendar.
PQX1 earnings for the last quarter are 0.17 EUR per share, whereas the estimation was 0.07 EUR resulting in a 128.00% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about BIOTAGE AB earnings.
BIOTAGE AB revenue for the last quarter amounts to ‪57.50 M‬ EUR despite the estimated figure of ‪48.45 M‬ EUR. In the next quarter revenue is expected to reach ‪39.83 M‬ EUR.
Yes, you can track BIOTAGE AB financials in yearly and quarterly reports right on TradingView.
PQX1 net income for the last quarter is ‪2.86 M‬ EUR, while the quarter before that showed ‪11.71 M‬ EUR of net income which accounts for −75.62% change. Track more BIOTAGE AB financial stats to get the full picture.
Yes, PQX1 dividends are paid annually. The last dividend per share was 0.14 EUR. As of today, Dividend Yield (TTM)% is 0.97%. Tracking BIOTAGE AB dividends might help you take more informed decisions.
BIOTAGE AB dividend yield was 1.20% in 2023, and payout ratio reached 48.03%. The year before the numbers were 0.86% and 39.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, PQX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTAGE AB stock right from TradingView charts — choose your broker and connect to your account.
PQX1 reached its all-time high on Nov 1, 2021 with the price of 29.080 EUR, and its all-time low was 0.396 EUR and was reached on Mar 6, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has 674.00 employees. See our rating of the largest employees — is BIOTAGE AB on this list?
We've gathered analysts' opinions on BIOTAGE AB future price: according to them, PQX1 price has a max estimate of 22.26 EUR and a min estimate of 13.70 EUR. Read a more detailed BIOTAGE AB forecast: see what analysts think of BIOTAGE AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOTAGE AB EBITDA is ‪44.75 M‬ EUR, and current EBITDA margin is 28.20%. See more stats in BIOTAGE AB financial statements.